Lorenzo Galluzzi

Nature Reviews Immunology Review on the Immunology of Breast Cancer - Lorenzo Galluzzi (@deadoc80) oncodaily.com/voices/lorenzo… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter

@deadoc80 @NatRevImmunol @bk_esme @txi_ber @LoiSher @FoxChaseCancer @PeterMacCC We would like to inform you that your post has been published on OncoDaily. Thank you for sharing! oncodaily.com/voices/lorenzo…

Proud to share our @NatRevImmunol review on the immunology of human breast cancer. Deeply grateful to @txi_ber, @loiSher, Roberto Salgado and @deadoc80 for making this collective effort possible!

Double-treat today! Also our latest @NatRevDrugDisc article on #autophagy and #cancer. Kudos to @EmmaGuilbaud for the heavy lifting here, and many thanks to Doug and Kev for their input. @FoxChaseCancer @CRUKScotland @StJudeResearch See rdcu.be/fji59

Happy to share our latest @NatRevImmunol review on the #immunology of breast #cancer in #patients. Kudos to @bk_esme and @txi_ber for the monumental effort. Not possible w/o critical input from @LoiSher & Roberto Salgado! @FoxChaseCancer @PeterMacCC See rdcu.be/fji5F

Also sharing our comment on a beautiful @Nature paper from @rafiahmed_lab demonstrating that PS exposure in activated T cells mediate #Tcellexhaustion in chronic #infection. Very relevant for #cancer, too. Kudos to @Mbv26 @FoxChaseCancer Free at rdcu.be/fifgE

Sharing our last @Nature_NPJ comment on data from @MSKCancerCenter in @Nature suggesting a link between #BRCA2 mutations and #resistance to CDK4/6i in #breastcancer. Kudos to @Flaviestem and Lukas for driving this. @FoxChaseCancer Free at rdcu.be/fibvl

Happy to share our @trendscancer commentary on a great @Nature paper showing that #ERstress in #cancer cells can also support immune evasion. Kudos to @luciaborriell! @FoxChaseCancer #threeCs Free at authors.elsevier.com/a/1msoZ8Z12yfK…

ICYMI

Here comes our latest @jitcancer review on #oncolytic #peptides for #cancer #immunotherapy. Kudos to Oliver for doing the hard lifting here. Available at jitc.bmj.com/content/14/2/e… @FoxChaseCancer @CRCordeliers

Glad to share our latest @SpringerNature view on 3 different original papers about extrachromosomal DNA and #cancer. Kudos to @IlioVitale and Alessandro for taking the lead on this. Free at rdcu.be/e2Z6V @FoxChaseCancer @fprc_candiolo

Glad to share our view on a recent @CellCellPress paper demonstrating an active role for melanosomes in #melanoma immunoescape. Thanks to @Yash_Chhabra and team for their critical input! Freely available at rdcu.be/e2fmm @FoxChaseCancer #threeCs

@BravoCorderoLab @FoxChaseCancer @FaneMitchell @Yash_Chhabra @PTorresAyuso @JanuszFranco @ednacukierman @luciaborriell It was great to have you on site! Thanks for visiting and sharing such such cool data on #breastcancer #metastasis and inspiring all of us as you did!

I had a great visit to @FoxChaseCancer catching up with old friends and learning about all the great science there @deadoc80 @FaneMitchell AitziberBuqueMartinez @Yash_Chhabra @PTorresAyuso Qing Chen @JanuszFranco @ednacukierman. Thanks so much for the invitation @luciaborriell

Typo in F1, totally my mistake! :-)

Happy to share our latest @sigtrans_sttt commentary on two beautiful @Nature papers on #ferroptosis and #cancer. Kudos to these 2 teams for their beautiful work! @j_ubellacker @luciaborriell @FoxChaseCancer nature.com/articles/s4139…

Review @Cancer_Cell @deadoc80 @FoxChaseCancer @univ_paris_cite Cancer cell death: Cell-autonomous and immunogenic dimensions cell.com/cancer-cell/fu…

Happy to end 2025 by sharing our latest @Cancer_Cell review discussing #celldeath in #cancer, and how the evolution of the cell death concept reshaped #oncology and #IO over the past 2 decades. @FoxChaseCancer @UTSWMedCenter @Crcordeliers Free at authors.elsevier.com/a/1mMl85TA51lD…

Pause for a moment and picture a small group of people you know well: colleagues, friends, the faces you pass each morning without thinking. Statistically, one in two of them will develop a malignant tumour at some point in their lifetime. And of that group, around a quarter will not survive it. These are not abstract numbers; they map directly onto ordinary lives, interrupted. Cancer is not rare, exceptional, or distant. It is woven into modern longevity itself. We need to study cancer, and to understand it at the deepest biological level, because only through that knowledge can treatments become more precise, more effective, and less destructive. But this effort is not limited to curing disease. It is also about learning how to support patients better. How to reduce suffering, preserve function, and protect dignity while biology is being fought at its limits.

A novel mechanism of immunoevasion by ER+ breast cancer dlvr.it/TPsZtS #immunology

Sharing our latest @trendscancer spotlight on #epigenetics as driver of #CIN and #chromosome #instability in #cancer, commenting on two recent @NatureGenet and @CD_AACR papers. Kudos to Ilio and Matteo for taking the lead @FoxChaseCancer @fpoirccs authors.elsevier.com/a/1mCdH8Z12ybX…